monocrotaline and Heritable Pulmonary Arterial Hypertension

monocrotaline has been researched along with Heritable Pulmonary Arterial Hypertension in 94 studies

Research

Studies (94)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's74 (78.72)24.3611
2020's20 (21.28)2.80

Authors

AuthorsStudies
Eklund, M; Khoruts, A; Moutsoglou, DM; Prins, KW; Prisco, AR; Prisco, SZ; Thenappan, T; Weir, EK1
Fu, Q; He, J; Li, M; Peng, J; Tan, S; Tang, M; Tang, Y; Xie, W; Xu, X; Zhang, Q; Zhang, Y; Zheng, Z; Zhu, T1
Amazit, L; Berrebeh, N; Chaumais, MC; Chelgham, MK; Guignabert, C; Huertas, A; Humbert, M; Le Vely, B; Ottaviani, M; Phan, C; Thuillet, R; Tu, L1
Carter, LL; Clemons, B; Douthitt, A; Galkin, A; Gandjeva, A; Garcia, E; Guimond, D; Kennedy, M; Osterhout, R; Salter-Cid, L; Sitapara, R; Slee, D; Tuder, RM; Zisman, LS1
Al-Qazazi, R; Archer, SL; Bentley, RET; Bonnet, S; Chen, KH; Dasgupta, A; Jones, O; Lima, PDA; Martin, AY; Maurice, DH; Mewburn, J; Potus, F; Prins, KW; Prisco, SZ; Provencher, S; Tian, L; Wu, D1
Aryan, L; Eghbali, M; Li, M; Medzikovic, L; Ruffenach, G1
Chen, S; Cui, H; Du, GQ; Li, Y; Shen, W; Sun, P; Wang, C; Xue, JY; Zhao, P1
Cao, M; Li, S; Liu, H; Luan, J; Wang, J; Xue, Y; Zhai, C; Zhang, N; Zhang, Q; Zhu, Y1
Chen, SA; Chen, YC; Chen, YJ; Higa, S; Kao, YH; Lin, FJ; Lu, YY1
Lin, S; Ma, H; Ye, P; Yu, WD; Zhang, AK; Zheng, YG1
Abid, S; Adnot, S; Beaulieu, D; Bernard, D; Born, E; Breau, M; Bulavin, DV; Delcroix, M; Derumeaux, G; Do Cruzeiro, M; Flaman, JM; Gil, J; Houssaini, A; Lefevre, M; Lipskaia, L; Marcos, E; Pierre, R; Quarck, R; Reen, V1
Liu, Y; Nie, X; Qi, Y; Shang, J; Wu, Z; Zhu, L1
Chen, YL; Chiang, JY; Guo, J; Huang, CR; Lin, KC; Shao, PL; Sung, PH; Yeh, JN; Yip, HK1
Ajijola, OA; Banerjee, S; Fishbein, G; Hong, J; Magaki, S; Razee, A; Umar, S1
Chen, L; Fan, F; Guan, Y; He, H; Liu, M; Qiu, L; Yang, G; Zheng, F1
Araujo, ASDR; Belló-Klein, A; Campos-Carraro, C; de Lima-Seolin, BG; Teixeira, RB; Turck, P; Zimmer, A1
Bo, Y; Cui, Z; Tianxin, Y; Weiguo, W; Yi, Y; Zhangchi, L1
Artigues, E; Cortijo, J; Escrivá, J; Milara, J; Montero, P; Perez-Vizcaino, F; Roger, I1
Chen, C; Chen, J; Chen, S; Das, A; Fang, Z; Hu, X; Huang, Y; Li, F; Luo, F; Wu, P; Zhou, S1
Nayeem, MJ; Sato, M; Yamamura, A1
Choi, SJ; Hong, YM; Kim, KC; Lee, H1
Didiasova, M; Gungl, A; Klepetko, W; Kosanovic, D; Kwapiszewska, G; Petrovic, A; Schaefer, L; Schermuly, RT; Wujak, L; Wygrecka, M; Zucker, MM1
Huang, CH; Huang, H; Li, YY; Liu, JC; Liu, ZB; Wu, QC; Xu, H; Xu, QR; Zeng, L; Zhou, XL; Zhu, RR1
Baal, N; Dorfmuller, P; Ghofrani, HA; Grimminger, F; Jonigk, D; Kojonazarov, B; Neubauer, MC; Neubert, L; Pullamsetti, SS; Ruppert, C; Schermuly, RT; Schlueter, BC; Seeger, W; Weiss, A; Weissmann, N; Yerabolu, D1
Guo, SS; Han, ZY; He, YY; Jing, ZC; Lin, JH; Pang, XB; Wang, Y; Wang, Z; Xie, XM; Yan, Y; Ye, J; Zhang, JL; Zhao, JH1
Chowdhury, HM; Li, X; Long, L; Morrell, NW; Nasim, MT; Ogo, T; Schermuly, RT; Torres Cleuren, YN; Trembath, RC; Yang, J1
Jasińska-Stroschein, M; Orszulak-Michalak, D; Owczarek, J; Łuczak, A1
Cantoni, S; Galiè, N; Galletti, M; Pasquinelli, G; Ponti, F; Tassinari, R; Valente, S; Ventura, C; Zambelli, F1
Barrier, M; Biardel, S; Bisserier, M; Bonnet, P; Bonnet, S; Breuils-Bonnet, S; Carter, S; Courchesne, A; Courture, C; Deshaies, Y; Lauzon-Joset, JF; Majka, SM; Meloche, J; Paulin, R; Picard, F; Provencher, S; Racine, C; Tremblay, É1
Bi, LQ; Kong, H; Kou, JP; Li, N; Wang, H; Wu, SL; Xie, WP; Yu, BY; Zhou, SM; Zhu, R; Zuo, XR1
Comunoglu, C; Macit, A; Silan, C; Uzun, O; Yavuz, O; Yavuz, T; Yildirim, HA; Yuksel, H1
Arai, H; Doi, S; Haraguchi, G; Hosokawa, S; Isobe, M; Itai, A; Mizutani, S; Muto, S; Sasaki, A1
Fan, YF; Jiang, X; Jing, ZC; Liu, D; Wang, YL; Wen, L; Wu, DC; Yuan, P; Zhang, R1
Li, G; Li, X; Li, Z; Liu, A; Liu, Y; Su, J; Sun, L; Xu, Y; Zhu, Y1
Bartelds, B; Berger, RM; Borgdorff, MA; de Vroomen, M; Dickinson, MG; Steendijk, P1
Aguero, J; Benard, L; Dorfmüller, P; Guignabert, C; Hadri, L; Hajjar, RJ; Hulot, JS; Humbert, M; Ibanez, B; Ishikawa, K; Kawase, Y; Kohlbrenner, E; Kratlian, RG; Ladage, D; Leopold, JA; Liang, L; Maron, BA; Turnbull, IC; Zsebo, K1
Chen, Z; Dixon, RA; Ruan, KH; So, SP; Vanderslice, P; Willerson, JT; Zhou, L1
Cheng, G; Lu, Y; Luan, Y; Zhang, Z1
Aliotta, JM; Amaral, A; El-Bizri, R; Hasslinger, A; Igbinoba, Z; Klinger, JR; Pereira, M; Quesenberry, PJ; Rounds, SI; Sorokina, A1
Guan, RJ; Jiang, H; Wang, HY1
Bergmeister, H; Bonderman, D; Jakowitsch, J; Lang, IM; Mascherbauer, J; Panzenböck, A; Schreiber, C; Strobl, M; Wexberg, P; Winter, MP1
Aboagye, EO; Ashek, A; Barnes, G; Cotroneo, E; Cupitt, J; Dabral, S; Dubois, O; El-Bahrawy, MA; Fang, W; Gibbs, JS; Gsell, W; He, JG; Howard, LS; Jones, H; Nguyen, QD; Pullamsetti, SS; Tomasi, G; Wang, L; Wilkins, MR; Zhao, L1
Chang, HW; Chen, YL; Chua, S; Chung, SY; Hsu, SY; Lee, FY; Leu, S; Lu, HI; Sheu, JJ; Sun, CK; Tsai, TH; Yip, HK; Zhen, YY1
Martínez, MC1
Bonnet, S; Breuils-Bonnet, S; Courboulin, A; Couture, C; Graydon, C; Meloche, J; Michelakis, ED; Paulin, R; Pflieger, A; Potus, F; Provencher, S; Tremblay, E; Vaillancourt, M; Zervopoulos, S1
Bai, Y; Kang, J; Lian, GC; Liu, M; Wang, HL; Wang, HM; Wang, Y; Zhang, XH1
Chen, YF; Creighton, JR; Fu, J; Guo, Y; Hage, FG; Oparil, S; Xing, DD; Zhao, X1
Brinckmann, J; Herold, S; Mayer, K; Mižíková, I; Morty, RE; Nave, AH; Niess, G; Reichenberger, F; Seeger, W; Steenbock, H; Talavera, ML; Vadász, I; Veit, F; Weissmann, N1
Asmis, R; Barabutis, N; Barman, SA; Black, SM; Catravas, JD; Chen, F; Dimitropoulou, C; Fulton, DJ; Giannis, A; Han, W; Jonigk, D; Keri, G; Orfi, L; Rafikov, R; Rafikova, O; Ramesh, G; Stepp, DW; Su, Y; Szabadkai, I; Szantai-Kis, C; Wang, Y1
Isenberg, JS; Rogers, NM1
Dai, Z; Guo, Z; Hu, W; Huang, C; Jiang, X; Tang, Y; Wang, X; Yang, B; Yu, S; Zhang, S; Zhao, Q1
Aliotta, JM; Baird, GL; Del Tatto, M; Dooner, MS; Goldberg, LR; Klinger, JR; Papa, E; Pereira, M; Quesenberry, PJ; Ventetuolo, CE; Wen, S1
Chen, C; He, JG; Huang, SA; Lei, W; Luo, P; Wu, YC1
de Boer, MA; Mouchaers, KT; Postmus, PE; Schalij, I; van der Laarse, WJ; van Hinsbergh, VW; van Nieuw Amerongen, GP; Vonk Noordegraaf, A1
Adcock, IM; Chaumais, MC; Dorfmüller, P; Gambaryan, N; Howard, LS; Humbert, M; Montani, D; Perros, F; Price, LC; Shao, DM; Simonneau, G; Souza, R; Tcherakian, C; Wort, SJ1
Chen, B; Guo, H; Tang, WL; Wang, X; Yang, J1
Han, DD; Li, XQ; Wang, HL; Wang, HM; Yang, CG; Zhang, XH1
Arai, K; Hiramine, K; Ido, A; Kamimura, R; Nuruki, N; Sata, N; Setoyama, K; Tanaka, Y; Tsubouchi, H; Uto, H1
Chen, L; Li, Y; Ma, H; Xiao, J1
Jin, H; Mei, Y; Meng, F; Tian, W; Wang, H; Zhang, Z; Zhao, Y1
Angeli, FS; Bernstein, HS; Boyle, AJ; De Marco, T; Jahn, S; Koskenvuo, JW; Mirsky, R; Ritner, C; Sievers, RE; Yeghiazarians, Y; Yim, SM1
Chen, XY; Han, B; Hao, W; Jin, YP; Li, YT; Wang, W; Wang, YL1
Cornitescu, T; Dahal, BK; Ghofrani, HA; Grimminger, F; Hoffmann, J; Kaulen, C; Kosanovic, D; Kuebler, WM; Reiss, I; Savai, R; Schermuly, RT; Seeger, W; Weissmann, N1
Guan, RJ; Li, XL; Wu, ZY; Xu, QH1
Delbeck, M; Ellinghaus, P; Kast, R; Laux, V; Nickel, KF; Perzborn, E; Schäfer, S; Schermuly, RT; Strassburger, J; von Degenfeld, G1
Bache, RJ; Chen, Y; Fassett, J; Geurts, AM; Guo, H; Hu, D; Hu, X; Lu, Z; Ostertag, E; Somani, A; Tang, Q; Weir, EK; Xu, D; Xu, X; Xu, Y1
Bleackley, RC; Bonnet, S; Dromparis, P; Haromy, A; McMurtry, MS; Michelakis, ED; Sutendra, G1
Bisserier, M; Bonnet, S; Courboulin, A; Jacob, MH; Meloche, J; Paulin, R1
das Neves, LA; Gralinski, MR; Huang, J; Nikula, KJ; Senese, PB; Zopf, DA1
Belló-Klein, A; Berger, B; Leichsenring-Silva, F; Llesuy, S; Mosele, F; Tavares, AM1
Bartelds, B; Berger, RM; Boersma, B; Borgdorff, MA; Dickinson, MG; Molema, G; Sietsma, H; Takens, J; Weij, M; Wichers, P1
Dahan, D; Guibert, C; Komohara, Y; Marthan, R; Masuda, H; Morimatsu, Y; Ohnishi, K; Sakashita, N; Takeya, M1
Hamidi, SA; Jiang, YP; Lin, RZ; Lyubsky, S; Said, SI; Szema, AM1
Araujo, AS; Belló-Klein, A; Caron-Lienert, R; Colombo, R; Mosele, F; Ribeiro, MF; Tavares, AM1
Dahal, BK; Ghofrani, HA; Kojonazarov, B; Kwapiszewska, G; Markart, P; Marsh, LM; Meinhardt, A; Olschewski, A; Preissner, KT; Schermuly, RT; Seeger, W; Steinhoff, M; Taube, C; Weissmann, N; Wygrecka, M1
Hirata, Y; Morita, T; Nagai, R; Sahara, M; Sata, M1
Archer, SL; Chen, Y; Fang, YH; Hong, Z; Marsboom, G; Morrow, E; Piao, L; Pogoriler, J; Rehman, J; Ryan, JJ; Thenappan, T; Toth, PT; Weir, EK; Wu, X; Zhang, HJ1
Hu, H; Huang, ZS; Jiang, L; Jiang, YZ; Liu, P; Ouyang, HW; Song, XH; Zeng, CL; Zhu, LJ1
Guan, RJ; Li, JJ; Li, XL1
Barreiro, EJ; da Silva, JS; Lima, LM; Nunes, IK; Pontes, LB; Sudo, RT; Zapata-Sudo, G1
Dong, H; Fernandez, RA; Guo, Q; Makino, A; Pohl, NM; Smith, KA; Yamamura, A; Yamamura, H; Yuan, JX; Zeifman, A; Zimnicka, AM1
Chaumais, MC; De Man, FS; Dorfmüller, P; Eddahibi, S; Fadel, E; François, C; Girerd, B; Guignabert, C; Huertas, A; Humbert, M; Lecerf, F; Montani, D; Perros, F; Tu, L1
Anderson, T; Campen, MJ; Candelaria, G; Hesterman, J; Hoppin, J; Irwin, D; Lucas, S; Norenberg, J; Paffett, ML1
Wang, H; Wang, Q; Wang, YY; Xie, WP; Zhang, M; Zuo, XR1
Boonstra, A; de Man, FS; Dorfmüller, P; Eddahibi, S; Fadel, E; François, C; Guignabert, C; Handoko, ML; Humbert, M; Perros, F; Postmus, PE; Rain, S; Ruiter, G; Schalij, I; Simonneau, G; Tu, L; van der Velden, J; Vonk-Noordegraaf, A1
Cui, W; Li, J; Long, C; Wang, H1
de Man, FS; Handoko, ML; Manders, E; Ottenheijm, CA; Stienen, GJ; van Hees, HW; Vonk-Noordegraaf, A; Westerhof, N1
Ji, YQ; Liu, CP; Lu, WX; Zeng, Q; Zhang, WH; Zhang, YJ1
Ceribasi, AO; Demir, T; Kaplan, DS; Kisacik, B; Onat, AM; Orkmez, M; Pehlivan, Y; Sayarlioglu, M; Taysi, S; Turkbeyler, IH; Tutar, E1
Fang, X; Fung, ML; Huang, Y; Liu, Y; Mao, G; Shyy, JY; Tian, XY; Wang, N1
Al-Lamki, RS; Berk, J; Li, X; Morrell, NW; Schermuly, RT; Weiss, A; Wu, C; Yang, J1
Bai, Y; Liu, M; Sun, YX; Wang, HL; Wang, HM; Wang, Y; Zhang, XH1
Chai, HT; Chang, HW; Chang, LT; Chen, YL; Chua, S; Chung, SY; Ko, SF; Leu, S; Sun, CK; Tsai, CY; Tsai, TH; Yen, CH; Yip, HK1
Barreiro, EJ; do Nascimento, JH; Ferraz, EB; Fraga, CA; Kummerle, AE; Pereira, SL; Rocha, Nde N; Sudo, RT; Zapata-Sudo, G1

Trials

1 trial(s) available for monocrotaline and Heritable Pulmonary Arterial Hypertension

ArticleYear
Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
    Circulation, 2013, Sep-10, Volume: 128, Issue:11

    Topics: Adult; Aged; Animals; Benzamides; Cell Division; Dichloroacetic Acid; Disease Models, Animal; Drug Monitoring; Familial Primary Pulmonary Hypertension; Female; Fibroblasts; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Glycolysis; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Indoles; Lung; Male; Middle Aged; Monocrotaline; Piperazines; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Sunitinib; Young Adult

2013

Other Studies

93 other study(ies) available for monocrotaline and Heritable Pulmonary Arterial Hypertension

ArticleYear
Intermittent Fasting Enhances Right Ventricular Function in Preclinical Pulmonary Arterial Hypertension.
    Journal of the American Heart Association, 2021, 11-16, Volume: 10, Issue:22

    Topics: Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Fasting; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Myocytes, Cardiac; Pulmonary Arterial Hypertension; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Right; Ventricular Function, Right

2021
Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
    BMC pulmonary medicine, 2022, Apr-12, Volume: 22, Issue:1

    Topics: Animals; Benzhydryl Compounds; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Glucosides; Humans; Hypertension, Pulmonary; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Sildenafil Citrate; Vascular Remodeling

2022
Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.
    American journal of respiratory cell and molecular biology, 2022, Volume: 67, Issue:2

    Topics: Animals; Disease Models, Animal; Endothelial Cells; Familial Primary Pulmonary Hypertension; Humans; Monocrotaline; Protein-Tyrosine Kinases; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats

2022
Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension.
    The European respiratory journal, 2022, Volume: 60, Issue:6

    Topics: Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Hypoxia; Imatinib Mesylate; MicroRNAs; Monocrotaline; Protein Kinase Inhibitors; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats

2022
Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    American journal of respiratory and critical care medicine, 2022, 09-01, Volume: 206, Issue:5

    Topics: Animals; Atrial Natriuretic Factor; Cytokine Receptor gp130; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Fibrosis; Heart Failure; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Inflammasomes; Macrophage Activation; Macrophages; Monocrotaline; NLR Family, Pyrin Domain-Containing 3 Protein; Pulmonary Arterial Hypertension; Rats; Ventricular Dysfunction, Right

2022
HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension.
    Circulation, 2022, 10-18, Volume: 146, Issue:16

    Topics: Animals; Cell Proliferation; Familial Primary Pulmonary Hypertension; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Hypertension, Pulmonary; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenotype; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; RNA; RNA-Binding Proteins

2022
Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
    European journal of pharmacology, 2022, Oct-15, Volume: 933

    Topics: Animals; Antioxidants; Arginine Vasopressin; Cysteine; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hepatocyte Growth Factor; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Malondialdehyde; Melatonin; Monocrotaline; NF-E2-Related Factor 2; Proto-Oncogene Proteins; Pulmonary Arterial Hypertension; Rats; RNA, Small Interfering; Ventricular Remodeling

2022
Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation.
    Lung, 2022, Volume: 200, Issue:5

    Topics: Actins; Animals; Autophagy; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Forkhead Box Protein M1; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Ki-67 Antigen; Monocrotaline; Phosphorylation; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Sprague-Dawley

2022
Role of Endothelin-1 in Right Atrial Arrhythmogenesis in Rabbits with Monocrotaline-Induced Pulmonary Arterial Hypertension.
    International journal of molecular sciences, 2022, Sep-20, Volume: 23, Issue:19

    Topics: Animals; Arrhythmias, Cardiac; Connexin 43; Disease Models, Animal; Endothelin-1; Familial Primary Pulmonary Hypertension; Monocrotaline; Proto-Oncogene Proteins c-akt; Pulmonary Arterial Hypertension; Pulmonary Artery; Rabbits

2022
Upregulation of miR-335-5p Contributes to Right Ventricular Remodeling via Calumenin in Pulmonary Arterial Hypertension.
    BioMed research international, 2022, Volume: 2022

    Topics: Angiotensin II; Animals; Antagomirs; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypoxia; Mice; MicroRNAs; Monocrotaline; Pulmonary Arterial Hypertension; Rats; Up-Regulation; Ventricular Remodeling

2022
Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
    Circulation, 2023, 02-21, Volume: 147, Issue:8

    Topics: Animals; Cellular Senescence; Endothelial Cells; Familial Primary Pulmonary Hypertension; Forkhead Transcription Factors; Hypertension, Pulmonary; Hypoxia; Mice; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Senotherapeutics

2023
Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
    European journal of pharmacology, 2023, Mar-15, Volume: 943

    Topics: Animals; Cell Transdifferentiation; Disease Models, Animal; Endothelial Cells; Familial Primary Pulmonary Hypertension; Glycogen Synthase Kinase 3 beta; Hypertension, Pulmonary; Male; Monocrotaline; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction

2023
Jagged/Notch proteins promote endothelial-mesenchymal transition-mediated pulmonary arterial hypertension via upregulation of the expression of GATAs.
    Journal of cellular and molecular medicine, 2023, Volume: 27, Issue:8

    Topics: Animals; Familial Primary Pulmonary Hypertension; Fibronectins; Monocrotaline; Pulmonary Arterial Hypertension; Receptors, Notch; Serrate-Jagged Proteins; Up-Regulation; Vimentin

2023
Thoracic Spinal Cord Neuroinflammation as a Novel Therapeutic Target in Pulmonary Hypertension.
    Hypertension (Dallas, Tex. : 1979), 2023, Volume: 80, Issue:6

    Topics: Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Minocycline; Monocrotaline; Neuroinflammatory Diseases; Pulmonary Arterial Hypertension; Rats; Rats, Sprague-Dawley; Spinal Cord

2023
Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90α axis.
    Journal of molecular and cellular cardiology, 2023, Volume: 181

    Topics: Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Heat-Shock Proteins; Hypertension, Pulmonary; Hypoxia; Mice; Monocrotaline; Myocytes, Smooth Muscle; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Vascular Remodeling

2023
Copaiba oil improves pulmonary nitric oxide bioavailability in monocrotaline-treated rats.
    Canadian journal of physiology and pharmacology, 2023, Sep-01, Volume: 101, Issue:9

    Topics: Animals; Antioxidants; Biological Availability; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Monocrotaline; Nitric Oxide; Oils, Volatile; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Wistar

2023
Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
    European journal of pharmacology, 2023, Dec-05, Volume: 960

    Topics: Animals; Atrial Fibrillation; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Fibrosis; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vascular Remodeling

2023
Targeting IL-11 system as a treatment of pulmonary arterial hypertension.
    Pharmacological research, 2023, Volume: 197

    Topics: Animals; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Interleukin-11; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; RNA, Small Interfering

2023
Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:4

    Topics: Adult; Animals; Biomarkers; Case-Control Studies; China; Chromatography, High Pressure Liquid; Discriminant Analysis; Familial Primary Pulmonary Hypertension; Fatty Acids; Female; Humans; Lipid Metabolism; Male; Mass Spectrometry; Metabolic Networks and Pathways; Metabolomics; Monocrotaline; Rats; Rats, Sprague-Dawley

2020
The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
    Biochemical and biophysical research communications, 2021, 01-01, Volume: 534

    Topics: Animals; Cell Line; Cell Proliferation; Familial Primary Pulmonary Hypertension; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Monocrotaline; Muscle, Smooth, Vascular; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats, Sprague-Dawley; rho-Associated Kinases; Up-Regulation; Vascular Remodeling

2021
Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats.
    Yonsei medical journal, 2017, Volume: 58, Issue:3

    Topics: Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Monocrotaline; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Time Factors

2017
LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
    Biochimica et biophysica acta. Molecular basis of disease, 2019, 06-01, Volume: 1865, Issue:6

    Topics: Actins; Adult; Animals; Antibodies, Neutralizing; Becaplermin; Case-Control Studies; Cell Dedifferentiation; Cell Proliferation; Collagen Type I; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Fibronectins; Gene Expression Regulation; Homeostasis; Humans; Integrin beta1; Low Density Lipoprotein Receptor-Related Protein-1; Male; Mice; Middle Aged; Monocrotaline; Myocytes, Smooth Muscle; Nuclear Proteins; Pulmonary Artery; Rats; Receptors, Platelet-Derived Growth Factor; RNA, Small Interfering; Signal Transduction; Tissue Culture Techniques; Trans-Activators

2019
NSD2 silencing alleviates pulmonary arterial hypertension by inhibiting trehalose metabolism and autophagy.
    Clinical science (London, England : 1979), 2019, 05-31, Volume: 133, Issue:9

    Topics: Animals; Autophagy; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hemodynamics; Histone-Lysine N-Methyltransferase; Hypertrophy, Right Ventricular; Lung; Male; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats, Sprague-Dawley; Vascular Remodeling

2019
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension.
    Nature communications, 2019, 05-17, Volume: 10, Issue:1

    Topics: Animals; Cell Line; Cyclin-Dependent Kinases; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Indoles; Lung; Male; Mice; Mice, Inbred C57BL; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Piperazines; Protein Kinase Inhibitors; Pulmonary Artery; Pyridines; Pyrroles; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Treatment Outcome

2019
Circulating Plasma Metabolomic Profiles Differentiate Rodent Models of Pulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension Patients.
    American journal of hypertension, 2019, 10-16, Volume: 32, Issue:11

    Topics: Adult; Animals; Biomarkers; Case-Control Studies; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Hypoxia; Male; Metabolomics; Methionine; Monocrotaline; Rats, Sprague-Dawley; Urea

2019
Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension.
    American journal of respiratory cell and molecular biology, 2013, Volume: 48, Issue:6

    Topics: Animals; Bone Morphogenetic Protein Receptors, Type II; Cell Proliferation; Codon, Nonsense; Epoprostenol; Familial Primary Pulmonary Hypertension; HEK293 Cells; Humans; Hypertension, Pulmonary; Lung; Male; MAP Kinase Signaling System; Mice; Monocrotaline; Myocytes, Smooth Muscle; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Smad3 Protein; Transforming Growth Factor beta1

2013
The beneficial impact of fasudil and sildenafil on monocrotaline-induced pulmonary hypertension in rats: a hemodynamic and biochemical study.
    Pharmacology, 2013, Volume: 91, Issue:3-4

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cholesterol, HDL; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; Natriuretic Peptide, Brain; Phosphodiesterase 5 Inhibitors; Piperazines; Protein Kinase Inhibitors; Purines; Rats; Rats, Wistar; rho-Associated Kinases; Sildenafil Citrate; Sulfones; Vascular Endothelial Growth Factor A

2013
Sodium butyrate inhibits platelet-derived growth factor-induced proliferation and migration in pulmonary artery smooth muscle cells through Akt inhibition.
    The FEBS journal, 2013, Volume: 280, Issue:9

    Topics: Acetylation; Animals; Butyric Acid; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Chromones; Familial Primary Pulmonary Hypertension; Gene Expression; Histone Deacetylase Inhibitors; Hypertension, Pulmonary; Male; Monocrotaline; Morpholines; Myocytes, Smooth Muscle; Phosphorylation; Platelet-Derived Growth Factor; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Tissue Culture Techniques

2013
Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Journal of the American Heart Association, 2013, Jan-16, Volume: 2, Issue:1

    Topics: Adult; Aged; Animals; Apoptosis; Arterial Pressure; Bone Morphogenetic Protein Receptors, Type II; Case-Control Studies; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Glycation End Products, Advanced; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indoles; Male; Middle Aged; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; RNA Interference; S100 Proteins; Signal Transduction; STAT3 Transcription Factor; Transfection; Up-Regulation

2013
Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats.
    International immunopharmacology, 2013, Volume: 16, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Arterial Pressure; Caveolin 1; Endothelium, Vascular; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Interleukin-1beta; Male; Monocrotaline; NF-kappa B; Nitric Oxide Synthase Type III; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Spirostans; Thromboplastin

2013
Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension.
    Pathology, research and practice, 2013, Volume: 209, Issue:5

    Topics: Animals; Antioxidants; Disease Models, Animal; Endothelium, Vascular; Erythrocytes; Familial Primary Pulmonary Hypertension; Hematocrit; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Malondialdehyde; Monocrotaline; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thiocarbamates

2013
Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Cardiovascular research, 2013, Jul-01, Volume: 99, Issue:1

    Topics: Animals; Antihypertensive Agents; Apoptosis; Benzamides; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Feedback, Physiological; Fibroblast Growth Factor 2; Hypertension, Pulmonary; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Pulmonary Artery; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Time Factors; Tissue Plasminogen Activator; Transcription Factor RelA; Ventricular Function, Right; Ventricular Pressure

2013
The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension.
    Cardiovascular research, 2013, Aug-01, Volume: 99, Issue:3

    Topics: Adolescent; Adult; Animals; Case-Control Studies; Cell Proliferation; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Imidazoles; Male; Monocrotaline; Nitric Oxide; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Piperazines; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Sulfones; Triazines; Vardenafil Dihydrochloride; Young Adult

2013
ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
    Lung, 2013, Volume: 191, Issue:4

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Arterial Pressure; Cytoprotection; Disease Models, Animal; Endothelium, Vascular; Enzyme Activation; Enzyme Activators; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Naphthalenes; Neointima; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Resorcinols; Severity of Illness Index; Time Factors; Vasodilation

2013
Distinct loading conditions reveal various patterns of right ventricular adaptation.
    American journal of physiology. Heart and circulatory physiology, 2013, Aug-01, Volume: 305, Issue:3

    Topics: Adaptation, Physiological; Animals; Arteriovenous Shunt, Surgical; Constriction; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Heart Failure; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Models, Cardiovascular; Monocrotaline; Myocardial Contraction; Physical Exertion; Pulmonary Artery; Rats; Rats, Wistar; Stroke Volume; Time Factors; Ultrasonography; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Pressure

2013
Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
    Circulation, 2013, Jul-30, Volume: 128, Issue:5

    Topics: Animals; Cells, Cultured; Disease Models, Animal; Down-Regulation; Familial Primary Pulmonary Hypertension; Gene Transfer Techniques; Heart Ventricles; HEK293 Cells; Humans; Hypertension, Pulmonary; Male; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Random Allocation; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Treatment Outcome

2013
Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits.
    Circulation, 2013, Aug-27, Volume: 128, Issue:9

    Topics: Animals; Cyclooxygenase 1; Cytochrome P-450 Enzyme System; Disease Models, Animal; Endothelial Cells; Epoprostenol; Familial Primary Pulmonary Hypertension; Genetic Therapy; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Infusions, Intravenous; Intramolecular Oxidoreductases; Male; Monocrotaline; Rats; Rats, Inbred F344; Stem Cell Transplantation; Survival Rate; Tissue Engineering; Transfection; Treatment Outcome

2013
[Research on effects of bone marrow mononuclear cells implantation on model of experimental pulmonary artery hypertension].
    Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2013, Volume: 30, Issue:3

    Topics: Animals; Bone Marrow Cells; Cell Transplantation; Dogs; Familial Primary Pulmonary Hypertension; Female; Hypertension, Pulmonary; Leukocytes, Mononuclear; Male; Monocrotaline; Rats

2013
Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice.
    Cardiovascular research, 2013, Dec-01, Volume: 100, Issue:3

    Topics: Animals; Apoptosis; Bone Marrow Cells; Bone Marrow Transplantation; Cell Differentiation; Cell Lineage; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Mice; Mice, Inbred C57BL; MicroRNAs; Monocrotaline; Phenotype; RNA, Messenger; Stem Cells; Time Factors; Transport Vesicles

2013
[Fasudil reverses monocrotaline-induced pulmonary hypertension in rats].
    Zhonghua xin xue guan bing za zhi, 2013, Volume: 41, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Male; Monocrotaline; Protein Phosphatase 1; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Treatment Outcome

2013
Exhaled nitric oxide measurement to monitor pulmonary hypertension in a pneumonectomy-monocrotaline rat model.
    American journal of physiology. Lung cellular and molecular physiology, 2013, Oct-01, Volume: 305, Issue:7

    Topics: Animals; Arginine; Arterial Pressure; Biomarkers; Biopterins; Exhalation; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Nitric Oxide; Pneumonectomy; Pulmonary Artery; Random Allocation; Rats; Rats, Sprague-Dawley

2013
Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013, Nov-20, Volume: 50, Issue:3-4

    Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; bcl-2-Associated X Protein; Caspase 3; Cell Cycle Checkpoints; Cell Line; Colchicine; Connexin 43; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Heart Ventricles; Hypertension, Pulmonary; Lung; Male; Matrix Metalloproteinase 9; Monocrotaline; Myocytes, Smooth Muscle; NF-kappa B; Nicorandil; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Smad3 Protein; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1

2013
Extracellular vesicles: small but strong.
    Cardiovascular research, 2013, Dec-01, Volume: 100, Issue:3

    Topics: Animals; Bone Marrow Cells; Endothelial Cells; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Lung; Monocrotaline; Stem Cells; Transport Vesicles

2013
Role for DNA damage signaling in pulmonary arterial hypertension.
    Circulation, 2014, Feb-18, Volume: 129, Issue:7

    Topics: Adult; Aged; Animals; Apoptosis; Benzimidazoles; Cell Proliferation; Cells, Cultured; Disease Models, Animal; DNA Damage; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; Male; MicroRNAs; Middle Aged; Monocrotaline; NFATC Transcription Factors; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Signal Transduction

2014
4-Chloro-DL-phenylalanine protects against monocrotaline‑induced pulmonary vascular remodeling and lung inflammation.
    International journal of molecular medicine, 2014, Volume: 33, Issue:2

    Topics: Animals; Disease Models, Animal; Down-Regulation; Familial Primary Pulmonary Hypertension; Fenclonine; Hypertension, Pulmonary; Intercellular Adhesion Molecule-1; Interleukin-1beta; Lung; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Monocrotaline; Phenylalanine; Pneumonia; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tryptophan Hydroxylase; Tumor Necrosis Factor-alpha

2014
Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.
    Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:7

    Topics: Adenoviridae; Animals; Arterial Pressure; Cells, Cultured; Chemokine CCL2; Chemokines, CXC; Disease Models, Animal; Endothelial Cells; Familial Primary Pulmonary Hypertension; Female; Genetic Therapy; Genetic Vectors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Macrophages; Monocrotaline; Neutrophil Infiltration; Neutrophils; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Ovariectomy; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-8; Transduction, Genetic; Up-Regulation; Ventricular Function, Right; Ventricular Remodeling

2014
Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:7

    Topics: Adult; Aged, 80 and over; Animals; Antihypertensive Agents; Case-Control Studies; Cell Hypoxia; Cells, Cultured; Collagen; Disease Models, Animal; Elastin; Enzyme Inhibitors; Familial Primary Pulmonary Hypertension; Female; Fibroblasts; Gene Expression Regulation, Enzymologic; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Isoenzymes; Male; Mice; Middle Aged; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protein-Lysine 6-Oxidase; Pulmonary Artery; Rats; RNA, Messenger; Ventricular Dysfunction, Right; Young Adult

2014
NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.
    Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:8

    Topics: Adventitia; Animals; Antihypertensive Agents; Cell Movement; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Matrix; Familial Primary Pulmonary Hypertension; Fibroblasts; HEK293 Cells; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indoles; Male; Mice; Mice, Inbred C57BL; Monocrotaline; NADPH Oxidase 4; NADPH Oxidases; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Time Factors; Transfection; Up-Regulation

2014
Endothelial cell global positioning system for pulmonary arterial hypertension: homing in on vascular repair.
    Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:7

    Topics: Animals; Endothelial Cells; Familial Primary Pulmonary Hypertension; Female; Genetic Therapy; Hypertension, Pulmonary; Monocrotaline; Pulmonary Artery; Receptors, Interleukin-8

2014
[Beneficial effects of renal denervation on pulmonary vascular remodeling in experimental pulmonary artery hypertension].
    Zhonghua yi xue za zhi, 2015, Apr-14, Volume: 95, Issue:14

    Topics: Angiotensin II; Animals; Blood Pressure; Denervation; Dogs; Echocardiography; Endothelin-1; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Kidney; Lung; Monocrotaline; Pulmonary Artery; Sympathectomy; Vascular Remodeling

2015
Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.
    Cardiovascular research, 2016, 06-01, Volume: 110, Issue:3

    Topics: Animals; Case-Control Studies; Cell-Derived Microparticles; Cells, Cultured; Disease Models, Animal; Exosomes; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice, Inbred C57BL; MicroRNAs; Monocrotaline; Pulmonary Artery; Vascular Remodeling

2016
[Gα11 expression and effect of sildenafil in muscularization of non-muscular pulmonary arterioles in rat with pulmonary arterial hypertension].
    Zhonghua yi xue za zhi, 2016, Jun-14, Volume: 96, Issue:22

    Topics: Animals; Arterioles; Familial Primary Pulmonary Hypertension; GTP-Binding Protein alpha Subunits, Gq-G11; Hypertension, Pulmonary; Lung; Monocrotaline; Muscle, Smooth, Vascular; Osteopontin; Piperazines; Random Allocation; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Vasodilator Agents

2016
Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    The European respiratory journal, 2010, Volume: 36, Issue:4

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Familial Primary Pulmonary Hypertension; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Monocrotaline; Piperazines; Pulmonary Artery; Purines; Rats; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilator Agents

2010
Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats.
    The European respiratory journal, 2011, Volume: 37, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Bone Morphogenetic Protein Receptors; Cell Proliferation; Dexamethasone; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Immunohistochemistry; Interleukin-6; Lung; Male; Monocrotaline; Muscle, Smooth; Rats; Rats, Wistar; Treatment Outcome

2011
Suppression of tissue inhibitors of metalloproteinases may reverse severe pulmonary arterial hypertension.
    Cytotherapy, 2011, Volume: 13, Issue:4

    Topics: Animals; Extracellular Matrix; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Matrix Metalloproteinases; Monocrotaline; RNA, Small Interfering; Tissue Inhibitor of Metalloproteinases

2011
Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats.
    Acta pharmacologica Sinica, 2011, Volume: 32, Issue:2

    Topics: Animals; Cytokines; Disease Models, Animal; Extracellular Matrix; Familial Primary Pulmonary Hypertension; Fluoxetine; Hypertension, Pulmonary; Inflammation; Lung; Male; Matrix Metalloproteinase Inhibitors; Monocrotaline; Pulmonary Artery; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Tissue Inhibitor of Metalloproteinases

2011
Hepatocyte growth factor improves the survival of rats with pulmonary arterial hypertension via the amelioration of pulmonary hemodynamics.
    International journal of molecular medicine, 2011, Volume: 27, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; C-Reactive Protein; Constriction, Pathologic; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Hemodynamics; Hepatocyte Growth Factor; Humans; Hypertension, Pulmonary; Male; Monocrotaline; Platelet-Derived Growth Factor; Pulmonary Artery; Rats; Rats, Wistar; Recombinant Proteins; Survival Analysis

2011
Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats.
    European review for medical and pharmacological sciences, 2011, Volume: 15, Issue:1

    Topics: Angiotensin I; Animals; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley

2011
Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Pulmonary pharmacology & therapeutics, 2011, Volume: 24, Issue:4

    Topics: Animals; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; Nitric Oxide; Organ Size; Peptide Fragments; Pulmonary Artery; Rats; Rats, Wistar; Urotensins; Vasodilation

2011
Treatment of pulmonary arterial hypertension with circulating angiogenic cells.
    American journal of physiology. Lung cellular and molecular physiology, 2011, Volume: 301, Issue:1

    Topics: Animals; Arteries; Cell Movement; Endothelial Cells; Familial Primary Pulmonary Hypertension; Hemodynamics; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Kaplan-Meier Estimate; Monocrotaline; Rats; Rats, Nude; Stem Cell Transplantation; Stem Cells; Ventricular Remodeling

2011
Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension.
    Molecular biology reports, 2011, Volume: 38, Issue:5

    Topics: Animals; Blood Pressure; Chemokine CX3CL1; CX3C Chemokine Receptor 1; Dexamethasone; Familial Primary Pulmonary Hypertension; Glucocorticoids; Hypertension, Pulmonary; Interferon-gamma; Interleukin-4; Lung; Male; Monocrotaline; Pulmonary Artery; Random Allocation; Rats; Rats, Wistar; Receptors, Chemokine

2011
Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats.
    Respiratory research, 2011, May-02, Volume: 12

    Topics: Animals; Cell Degranulation; Cromolyn Sodium; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Mast Cells; Monocrotaline; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Ventricular Function, Right; Ventricular Remodeling

2011
[Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Zhonghua xin xue guan bing za zhi, 2011, Volume: 39, Issue:3

    Topics: Animals; Cell Proliferation; Endothelial Cells; Familial Primary Pulmonary Hypertension; Fluorobenzenes; Hypertension, Pulmonary; Hypolipidemic Agents; Male; Monocrotaline; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type III; Proliferating Cell Nuclear Antigen; Pyrimidines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Rosuvastatin Calcium; Sulfonamides

2011
A role for coagulation factor Xa in experimental pulmonary arterial hypertension.
    Cardiovascular research, 2011, Oct-01, Volume: 92, Issue:1

    Topics: Animals; Blood Coagulation; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Morpholines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Rivaroxaban; Thiophenes; Thrombosis; Warfarin

2011
Exacerbated pulmonary arterial hypertension and right ventricular hypertrophy in animals with loss of function of extracellular superoxide dismutase.
    Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:2

    Topics: Animals; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Male; Mice; Mice, Knockout; Monocrotaline; Mutation; Rats; Superoxide Dismutase

2011
Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension.
    Journal of molecular medicine (Berlin, Germany), 2011, Volume: 89, Issue:8

    Topics: Animals; Etanercept; Familial Primary Pulmonary Hypertension; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypertension, Pulmonary; Immunoglobulin G; Inflammation Mediators; Ion Channel Gating; Ketone Oxidoreductases; Kv1.5 Potassium Channel; Models, Biological; Monocrotaline; Myocytes, Smooth Muscle; Phenotype; Pulmonary Artery; Rats; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha

2011
Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:5

    Topics: Adult; Animals; Antihypertensive Agents; Apoptosis; Blotting, Western; Bone Morphogenetic Protein Receptors, Type II; Calcium; Cell Proliferation; Cells, Cultured; Dehydroepiandrosterone; Disease Models, Animal; Enzyme Activation; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; In Situ Nick-End Labeling; Inhibitor of Apoptosis Proteins; Male; Membrane Potential, Mitochondrial; MicroRNAs; Microtubule-Associated Proteins; Middle Aged; Monocrotaline; Muscle, Smooth; Myocytes, Smooth Muscle; NFATC Transcription Factors; Proto-Oncogene Proteins c-pim-1; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Survivin; Vasodilator Agents

2011
C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    European journal of pharmacology, 2011, Nov-16, Volume: 670, Issue:1

    Topics: Animals; Arterioles; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Blood Proteins; Familial Primary Pulmonary Hypertension; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy; Male; Monocrotaline; Phenothiazines; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists

2011
Association of the time course of pulmonary arterial hypertension with changes in oxidative stress in the left ventricle.
    Clinical and experimental pharmacology & physiology, 2011, Volume: 38, Issue:12

    Topics: Animals; Ascorbic Acid; Cardiomegaly; Familial Primary Pulmonary Hypertension; Glutathione; Heart Ventricles; Hydrogen Peroxide; Hypertension, Pulmonary; Male; Monocrotaline; Oxidative Stress; Rats; Rats, Wistar; Thioredoxin-Disulfide Reductase; Ultrasonography

2011
Egr-1 expression during neointimal development in flow-associated pulmonary hypertension.
    The American journal of pathology, 2011, Volume: 179, Issue:5

    Topics: Animals; Arteriovenous Shunt, Surgical; Blood Flow Velocity; Early Growth Response Protein 1; Familial Primary Pulmonary Hypertension; Heart Defects, Congenital; Hemodynamics; Humans; Hypertension, Pulmonary; Immunohistochemistry; Monocrotaline; Neointima; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Repressor Proteins

2011
Development and characterization of an animal model of severe pulmonary arterial hypertension.
    Journal of vascular research, 2012, Volume: 49, Issue:1

    Topics: Animals; Chronic Disease; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Rats; Rats, Wistar; Tunica Media

2012
VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension.
    Respiratory research, 2011, Oct-26, Volume: 12

    Topics: Animals; Bosentan; Drug Therapy, Combination; Endothelin Receptor Antagonists; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Monocrotaline; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Sulfonamides; Vasoactive Intestinal Peptide

2011
Effects of purple grape juice in the redox-sensitive modulation of right ventricular remodeling in a pulmonary arterial hypertension model.
    Journal of cardiovascular pharmacology, 2012, Volume: 60, Issue:1

    Topics: Animals; Beverages; Caspase 3; Disease Models, Animal; Echocardiography; Familial Primary Pulmonary Hypertension; Hydrogen Peroxide; Hypertension, Pulmonary; Lipid Peroxidation; Male; Monocrotaline; Oxidation-Reduction; Rats; Rats, Wistar; Signal Transduction; Thioredoxins; Ventricular Remodeling; Vitis

2012
PAR-2 inhibition reverses experimental pulmonary hypertension.
    Circulation research, 2012, Apr-27, Volume: 110, Issue:9

    Topics: Adolescent; Adult; Animals; Antibodies, Neutralizing; Becaplermin; Benzamides; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Imatinib Mesylate; Ligands; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oligopeptides; Piperazines; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, PAR-2; Receptor, Platelet-Derived Growth Factor beta; RNA Interference; Signal Transduction; Time Factors; Transfection; Tryptases; Young Adult

2012
Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
    PloS one, 2012, Volume: 7, Issue:3

    Topics: Animals; Antihypertensive Agents; Apoptosis; Blotting, Western; Caspase 3; Cells, Cultured; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Familial Primary Pulmonary Hypertension; Glyburide; Human Umbilical Vein Endothelial Cells; Humans; Hypertension, Pulmonary; Injections, Intraperitoneal; Male; MAP Kinase Signaling System; Monocrotaline; NG-Nitroarginine Methyl Ester; Nicorandil; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Pressure

2012
Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
    Circulation research, 2012, May-25, Volume: 110, Issue:11

    Topics: Animals; Antihypertensive Agents; Case-Control Studies; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Proliferation; Cells, Cultured; Cobalt; Cyclin B1; Disease Models, Animal; Dynamins; Enzyme Activation; Familial Primary Pulmonary Hypertension; Genetic Therapy; Glycolysis; GTP Phosphohydrolases; Humans; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Microtubule-Associated Proteins; Mitochondria, Muscle; Mitochondrial Proteins; Mitosis; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Pulmonary Artery; Quinazolinones; Rats; Rats, Sprague-Dawley; RNA Interference; Serine; Time Factors; Transfection

2012
Platelet-mediated mesenchymal stem cells homing to the lung reduces monocrotaline-induced rat pulmonary hypertension.
    Cell transplantation, 2012, Volume: 21, Issue:7

    Topics: Animals; Antibodies; Blood Platelets; Blood Pressure; Bone Marrow Cells; Familial Primary Pulmonary Hypertension; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Lung; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Monocrotaline; P-Selectin; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Sprague-Dawley; Tirofiban; Tyrosine

2012
Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Journal of cardiovascular pharmacology, 2012, Volume: 60, Issue:2

    Topics: Animals; Antihypertensive Agents; Arterial Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Familial Primary Pulmonary Hypertension; Fluorobenzenes; Gene Expression Regulation, Enzymologic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Nitric Oxide Synthase Type III; Proliferating Cell Nuclear Antigen; Pulmonary Artery; Pyrimidines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; RNA, Messenger; Rosuvastatin Calcium; Sulfonamides; Time Factors

2012
Benzenesulfonamide attenuates monocrotaline-induced pulmonary arterial hypertension in a rat model.
    European journal of pharmacology, 2012, Sep-05, Volume: 690, Issue:1-3

    Topics: Animals; Benzenesulfonamides; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Wistar; Sulfonamides; Ventricular Pressure

2012
Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
    Circulation research, 2012, Aug-03, Volume: 111, Issue:4

    Topics: Aniline Compounds; Animals; Calcimimetic Agents; Calcium Signaling; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Mice; Mice, Inbred C57BL; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Naphthalenes; Phenethylamines; Propylamines; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; RNA Interference; Spermine; Time Factors; Transfection; Vasoconstriction

2012
A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.
    American journal of respiratory and critical care medicine, 2012, Oct-01, Volume: 186, Issue:7

    Topics: Animals; Benzamides; Benzimidazoles; Case-Control Studies; Crk-Associated Substrate Protein; Disease Models, Animal; Endothelial Cells; Epidermal Growth Factor; Familial Primary Pulmonary Hypertension; Fibroblast Growth Factor 2; Gefitinib; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Mice; Monocrotaline; Myocytes, Smooth Muscle; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pulmonary Artery; Pyrimidines; Quinazolines; Quinolones; Rats; Signal Transduction

2012
Longitudinal in vivo SPECT/CT imaging reveals morphological changes and cardiopulmonary apoptosis in a rodent model of pulmonary arterial hypertension.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Animals; Annexins; Apoptosis; Blood Pressure; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Heart Ventricles; Humans; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Myocardium; Perfusion; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Systole; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ventricular Remodeling

2012
Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats.
    Vascular pharmacology, 2013, Volume: 58, Issue:1-2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Disease Models, Animal; Etanercept; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Hypertension, Pulmonary; Immunoglobulin G; Inflammation; Lung; Male; Monocrotaline; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha

2013
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.
    American journal of respiratory and critical care medicine, 2012, Oct-15, Volume: 186, Issue:8

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Case-Control Studies; Cells, Cultured; Disease Progression; Endothelium, Vascular; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Losartan; Male; Middle Aged; Monocrotaline; Myocytes, Smooth Muscle; Proportional Hazards Models; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Up-Regulation

2012
Iptakalim ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
    Journal of cardiovascular pharmacology and therapeutics, 2013, Volume: 18, Issue:1

    Topics: Animals; Endothelin-1; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; KATP Channels; Lung; Male; Monocrotaline; Natriuretic Peptide, Brain; Nitric Oxide; Propylamines; Rats; Rats, Wistar

2013
Diaphragm weakness in pulmonary arterial hypertension: role of sarcomeric dysfunction.
    American journal of physiology. Lung cellular and molecular physiology, 2012, Dec-15, Volume: 303, Issue:12

    Topics: Animals; Calcium; Diaphragm; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Male; Monocrotaline; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Weakness; Myosin Heavy Chains; Rats; Rats, Wistar; Sarcomeres

2012
Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats.
    Scandinavian cardiovascular journal : SCJ, 2012, Volume: 46, Issue:6

    Topics: Animals; Antihypertensive Agents; Arterial Pressure; Arterioles; Carbolines; Disease Models, Animal; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Inflammation Mediators; Interleukin-6; Male; Monocrotaline; Phosphodiesterase 5 Inhibitors; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Simvastatin; Tadalafil; Time Factors; Vasodilator Agents

2012
Urotensin inhibition with palosuran could be a promising alternative in pulmonary arterial hypertension.
    Inflammation, 2013, Volume: 36, Issue:2

    Topics: Animals; Arterial Pressure; Arterioles; Endothelin-1; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Pulmonary Artery; Quinolines; Rats; Rats, Wistar; Transforming Growth Factor beta1; Urea; Urotensins

2013
Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:6

    Topics: Animals; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypoxia; Indoles; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Pulmonary Artery; Receptor, Serotonin, 5-HT2B; Rosiglitazone; Serotonin 5-HT2 Receptor Agonists; Thiazolidinediones; Thiophenes; Transcription Factor AP-1; Up-Regulation

2012
Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
    Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:1

    Topics: Animals; Antihypertensive Agents; Binding Sites; Bone Morphogenetic Protein 4; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Cell Proliferation; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Disease Models, Animal; Dose-Response Relationship, Drug; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Inhibitor of Differentiation Protein 1; Male; Monocrotaline; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; Phosphodiesterase 5 Inhibitors; Phosphorylation; Piperazines; Promoter Regions, Genetic; Pulmonary Artery; Purines; Rats; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Sildenafil Citrate; Smad1 Protein; Smad5 Protein; Sulfones; Transfection; Vasodilator Agents

2013
Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats.
    Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:11

    Topics: Airway Remodeling; Animals; Disease Models, Animal; Down-Regulation; Familial Primary Pulmonary Hypertension; Fluoxetine; Hypertension, Pulmonary; Isoenzymes; Lung; Male; MAP Kinase Signaling System; Monocrotaline; Phosphorylation; Protein Processing, Post-Translational; Protein Transport; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Random Allocation; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Selective Serotonin Reuptake Inhibitors

2012
Sildenafil improves long-term effect of endothelial progenitor cell-based treatment for monocrotaline-induced rat pulmonary arterial hypertension.
    Cytotherapy, 2013, Volume: 15, Issue:2

    Topics: Animals; Cell- and Tissue-Based Therapy; Combined Modality Therapy; Endothelial Cells; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Male; Monocrotaline; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Stem Cell Transplantation; Stem Cells; Sulfones; Time; Vasodilator Agents

2013
A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension.
    European journal of pharmacology, 2013, Feb-28, Volume: 702, Issue:1-3

    Topics: Acetylcholine; Animals; Benzodioxoles; Calcium Channel Blockers; Calcium Chloride; Cardiomegaly; Familial Primary Pulmonary Hypertension; Hydrazones; Hypertension, Pulmonary; In Vitro Techniques; Male; Monocrotaline; Phenylephrine; Pulmonary Artery; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilator Agents

2013